Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ENVB Financial Statements and Analysis

NASDAQ : ENVB

Enveric Biosciences, Inc.

$2.30
1.12+94.92%
At Close 4:00 PM
$1.90
-0.4-17.39%
After-Market 07:59 PM
65.81
BESG ScoreESG Rating

ENVB FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

ENVB Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue00000
cost of revenue084.779K85.409K84.682K95.839K
gross profit0-84.779K-85.409K-84.682K-95.839K
gross profit ratio00000
research and development expenses762.717K515.501K458.155K1.369M1.352M
general and administrative expenses1.236M1.298M1.934M2.779M2.01M
selling and marketing expenses000-1.848M201.862
selling general and administrative expenses1.236M1.298M1.934M930.681K2.01M
other expenses84.814K84.779K85.409K086.296K
operating expenses2.083M1.898M2.392M2.30M3.448M
cost and expenses2.083M1.898M2.477M2.384M3.448M
interest income000566.002.237K
interest expense00696.0002.237K
depreciation and amortization84.814K84.779K85.409K84.682K86.296K
ebitda-1.998M-1.813M-2.392M-2.30M-2.74M
ebitda ratio00000
operating income-2.083M-1.898M-2.477M-2.384M-3.448M
operating income ratio00000
total other income expenses net-840.0018.537K22.133K-1.029M632.774K
income before tax-2.084M-1.879M-2.455M-3.414M-2.816M
income before tax ratio00000
income tax expense001.731K22.318K-6.595K
net income-2.084M-1.879M-2.457M-3.436M-2.822M
net income ratio00000
eps-0.24-0.25-0.61-1.46-1.30
eps diluted-0.24-0.25-0.61-1.46-1.30
weighted average shs out8.703M7.588M4.001M2.349M2.165M
weighted average shs out dil8.703M7.588M4.001M2.349M2.165M
Graph

ENVB Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents3.112M3.503M6.356M2.288M4.267M
short term investments00000
cash and short term investments3.112M3.503M6.356M2.288M4.267M
net receivables17.758K299.316K0224.607K0
inventory-17.758K0-455.78K00
other current assets1.227M1.718M1.873M501.344K1.56M
total current assets4.338M5.52M8.229M3.014M5.827M
property plant equipment net367.689K405.114K452.228K507.376K539.152K
goodwill00000
intangible assets84.368K126.556K168.744K0253.12K
goodwill and intangible assets84.368K126.556K168.744K210.932K253.12K
long term investments0001.818M0
tax assets00000
other non current assets000567.603K0
total non current assets452.057K531.67K620.972K3.104M792.272K
other assets001.001.000
total assets4.79M6.052M8.85M6.117M6.619M
account payables576.324K459.898K1.853M1.219M1.098M
short term debt00000
tax payables00022.318K9.449K
deferred revenue00000
other current liabilities262.842K185.442K515.105K1.125M3.085M
total current liabilities839.166K645.34K2.368M2.344M4.184M
long term debt00000
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities00000
total non current liabilities00000
other liabilities00000
capital lease obligations00000
total liabilities839.166K645.34K2.368M2.344M4.184M
preferred stock00000
common stock89.949K78.785K72.939K27.392K21.818K
retained earnings-102.92M-100.836M-98.956M-96.50M-93.064M
accumulated other comprehensive income loss-534.998K-566.495K-551.843K-569.749K-535.619K
other total stockholders equity107.316M106.73M105.917M100.816M96.013M
total stockholders equity3.951M5.406M6.482M3.774M2.436M
total equity3.951M5.406M6.482M3.774M2.436M
total liabilities and stockholders equity4.79M6.052M8.85M6.117M6.619M
minority interest00000
total investments0001.818M0
total debt00000
net debt-3.112M-3.503M-6.356M-2.288M-4.267M
Graph

ENVB Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00-1.068M-3.36M0
stock based compensation369.614K351.488K364.728K372.859K879.738K
change in working capital-1.446M-556.892K205.839K243.629K298.27K
accounts receivables00000
inventory00000
accounts payables-1.661M202.397K-533.536K-112.709K-111.315K
other working capital215.467K-759.289K739.375K356.338K409.585K
other non cash items2.182M298.472K2.097M2.729M597.75K
net cash provided by operating activities-2.889M-2.598M-1.751M-2.74M-4.466M
investments in property plant and equipment3.00015.00-8.00-18.00
acquisitions net00-53.0028.0016.872K
purchases of investments00000
sales maturities of investments00000
other investing activites00000
net cash used for investing activites00-38.0020.0016.854K
debt repayment00000
common stock issued51.684K6.802M000
common stock repurchased0000-1.052M
dividends paid00000
other financing activites-17.254K-144.058K-186.084K-105.00K-1.052K
net cash used provided by financing activities34.43K6.658M-186.084K-105.00K-1.052M
effect of forex changes on cash1.258K8.137K-41.421K30.573K20.719K
net change in cash-2.853M4.068M-1.979M-2.815M-5.48M
cash at end of period3.503M6.356M2.288M4.267M7.081M
cash at beginning of period6.356M2.288M4.267M7.081M12.562M
operating cashflow-2.889M-2.598M-1.751M-2.74M-4.466M
capital expenditure3.00015.00-8.00-18.00
free cash flow-2.889M-2.598M-1.751M-2.74M-4.466M
Graph

Frequently Asked Questions

How did Enveric Biosciences, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, ENVB generated $0.00 in revenue last quarter, while its costs came in at $0.00.

Last quarter, how much Gross Profit did Enveric Biosciences, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Enveric Biosciences, Inc. reported a $0.00 Gross Profit for the quarter ended Jun 30, 2024.

Have ENVB's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. ENVB incurred $2.08M worth of Operating Expenses, while it generated -$2.08M worth of Operating Income.

How much Net Income has ENVB posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Enveric Biosciences, Inc., the company generated -$2.08M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Enveric Biosciences, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Enveric Biosciences, Inc. as of the end of the last quarter was $3.11M.

What are ENVB's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, ENVB had Total Net Receivables of $17.76K.

In terms of Total Assets and Current Assets, where did Enveric Biosciences, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of ENVB were $4.34M, while the Total Assets stand at $4.79M.

As of the last quarter, how much Total Debt did Enveric Biosciences, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of ENVB's debt was $0.00 at the end of the last quarter.

What were ENVB's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, ENVB reported total liabilities of $839.17K.

How much did ENVB's Working Capital change over the last quarter?

Working Capital Change for ENVB was -$1.45M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

ENVB generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. ENVB generated -$2.89M of Cash from Operating Activities during its recently reported quarter.

What was ENVB's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. ENVB reported a -$2.85M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph